Ameriprise Financial Inc Sight Sciences, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.44 - $13.35 $84 - $133	-10 Reduced 0.02%	64,876 $567,000
Q4 2022 Feb 14, 2023	BUY	$5.58 - $13.94 $362,063 - $904,510	64,886 New	64,886 $792,000
Q2 2022 Aug 15, 2022	BUY	$6.61 - $11.99 $19,856 - $36,017	3,004 Added 7.18%	44,840 $403,000
Q1 2022 May 16, 2022	BUY	$11.56 - $17.9 $54,621 - $84,577	4,725 Added 12.73%	41,836 $483,000
Q4 2021 Feb 14, 2022	SELL	$17.36 - $27.36 $25,293 - $39,863	-1,457 Reduced 3.78%	37,111 $652,000

Q3 2021 Nov 15, 2021	BUY	$22.34 - $39.1 $861,609 - $1.51 Million	38,568 New	38,568 $875,000

21.1M

33.2K

27.7K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $296M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.